Insider Trading April 3, 2026

Leonardo DRS CFO Executes $320,881 Stock Sale Under 10b5-1 Plan; Multiple Equity and Vesting Transactions Disclosed

Michael Dippold sold 7,071 shares April 2 while also recording numerous vesting and tax-withholding disposals tied to restricted awards; company activity includes major DoD contract position and new rugged computing product

By Derek Hwang DRS
Leonardo DRS CFO Executes $320,881 Stock Sale Under 10b5-1 Plan; Multiple Equity and Vesting Transactions Disclosed
DRS

Leonardo DRS Executive Vice President and Chief Financial Officer Michael Dippold completed a planned sale of 7,071 shares on April 2, 2026, for approximately $320,881 under a Rule 10b5-1 trading plan adopted June 13, 2025. Recent filings also show multiple share acquisitions via vesting and disposals to cover tax obligations. The disclosures arrive as the company reports new program wins, product launches and analyst target changes.

Key Points

  • CFO Michael Dippold sold 7,071 shares on April 2, 2026, at $45.38 per share under a Rule 10b5-1 trading plan adopted June 13, 2025, totaling about $320,881.
  • Form 4 filings show multiple vesting events on April 1, 2026, comprising 33,380 and 22,378 shares acquired at $0.0 and additional acquisitions of 10,360, 6,815 and 5,451 shares at $0.0, plus disposals to cover tax withholding totaling $1,566,440.
  • Company developments disclosed include a position on the ATSP5 contract vehicle potentially exceeding $25 billion over ten years, the launch of the THOR rugged computing system, analyst price target adjustments to $55 and $47, and the appointment of Reuben Jeffery III to the board effective April 1, 2026.

Leonardo DRS, Inc. reported an insider sale by Executive Vice President and Chief Financial Officer Michael Dippold, who sold 7,071 shares of common stock on April 2, 2026, at $45.38 per share, for total proceeds of about $320,881. The transaction was carried out pursuant to a Rule 10b5-1 trading plan that Dippold established on June 13, 2025.

Separately, a Form 4 filing with the Securities and Exchange Commission documents a series of share acquisitions for Dippold through the vesting of restricted stock units (RSUs) and performance restricted stock units (PRSUs). On April 1, 2026, the filing records that 33,380 and 22,378 shares of common stock vested and were acquired at a stated $0.0 per share, with a total value indicated as $0.0. In addition, the filing shows acquisitions of 10,360, 6,815 and 5,451 shares of common stock at $0.0.

The same April 1 filings also detail multiple disposals executed to satisfy tax withholding obligations. To cover withholding, Dippold disposed of 13,858, 10,093, 4,673, 3,074 and 2,459 shares at $45.86 per share, producing a combined value of $1,566,440 tied to those withholding events.

Market context included in the reporting indicates that Leonardo DRS shares were trading at $46.30 at the time of the disclosure, representing a 36% increase year-to-date. An analysis cited within the material notes that the stock appeared overvalued relative to its Fair Value, showing a price-to-earnings ratio of 45.

Company developments noted alongside the insider activity include Leonardo DRS’s award of a place on the Advanced Technology Support Program V (ATSP5), an indefinite-delivery, indefinite-quantity contract vehicle with the U.S. military that could, over a ten-year span, potentially exceed $25 billion. In addition, Leonardo DRS announced the introduction of THOR, a rugged computing system tailored for military vehicles and designed to align with the Department of Defense’s Modular Open Systems Approach.

Analyst attention cited in the filing material reflects shifts in price targets from two firms. BofA Securities raised its price target to $55, citing expected increases in demand for defense systems amid geopolitical tensions. Morgan Stanley adjusted its price target to $47 and highlighted the company’s efforts related to securing Germanium supply and its free cash flow conversion guidance.

Leadership changes disclosed include the addition of Reuben Jeffery III to Leonardo DRS’s board of directors, effective April 1, 2026.


These filings combine executive equity transactions with concurrent corporate developments, including contract awards, product launches and analyst coverage updates. The documentation shows both the exercise of equity vesting events and the planned disposition of shares under a pre-established trading plan, together with tax-related share disposals.

Risks

  • Equity transactions by executives can be interpreted variably by investors and may affect investor perception in the defense sector and equities markets.
  • The stock’s valuation metrics cited - a P/E of 45 and an appearance of being overvalued relative to Fair Value - present valuation risk for equity investors in Leonardo DRS.
  • Contract awards like ATSP5 are indefinite-delivery, indefinite-quantity arrangements; while the vehicle could potentially exceed $25 billion over ten years, the realization of revenue and timing are uncertain, posing program execution and defense contracting risk.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026